ACE Antibody (YA3478)
(Synonyms: Angiotensin Converting Enzyme 1; ACE; ACE-T; Angiotensin-converting enzyme isoform 1precursor; Dipeptidyl carboxy peptidase 1; Kininase II; ACE-1; testis-specific isoform precursor. ACE 1; ACE T; ACE1; Angiotensin converting enzyme somatic isoform; Angiotensin converting enzyme testis specific isoform; Angiotensin I converting enzyme; Angiotensin I converting enzyme 1; Angiotensin I converting enzyme peptidyl dipeptidase A 1; Carboxycathepsin; CD 143; CD143; CD143 antigen; DCP 1; DCP; DCP1; Dipeptidyl carboxypeptidase 1; MVCD3; Peptidase P; Peptidyl dipeptidase A; Testicular ECA; ACE_HUMAN.)
Based on 1 Customer Validation
ACE Antibody (YA3478) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to ACE.
-
Host:
Rabbit
-
Isotype:
IgG
-
Application:
WB, IHC-P, FC
-
Reactivity :
Human, Mouse
-
Formulation:
Supplied in 50mM Tris-Glycine(pH 7.4), 0.15M NaCl, 40%Glycerol, 0.01% sodium azide and 0.05% BSA.
-
Conjugation:
Non-conjugated
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
Applications
| Application |
WB
WB: Western Blot
|
IHC-P
IHC-P: Immunohistochemistry-Paraffin
|
FC
FC: Flow Cytometry
|
|---|---|---|---|
| Dilution Ratio | 1:1000-1:2000 | 1:100-1:200 | 1:50-1:100 |
Product Details
ACE Antibody (YA3478) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to ACE.
-
Host Rabbit
-
Clonality Monoclonal,Recombinant
-
Species ReactivityHuman, Mouse
-
Observed Molecular WeightObserved band size: 195 kDa
Note: Due to possible protein modifications or aggregation, the molecular weight should be confirmed by actual measurement, and the predicted value is for reference only.
-
Calculated Molecular Weight Predicted band size: 150 kDa
A synthesized peptide derived from human ACE1 aa1250-1306/1306.
Endogenous
affinity purified
Non-conjugated
Unmodified
IgG
Product Properties
-
Appearance
Solution
-
Formulation
Supplied in 50mM Tris-Glycine(pH 7.4), 0.15M NaCl, 40%Glycerol, 0.01% sodium azide and 0.05% BSA.
-
Concentration
Batch-dependent, Please check the COA for the concentration of each lot. Check Lot Concentration
-
Storage & Stability
Stored at -20°C for 1 year. Avoid repeated freeze / thaw cycles.
-
Shipping
Shipping with blue ice.
Background
-
Function
ACE is a two-domain dipeptidylcarboxypeptidase that regulates blood pressure through the renin-angiotensin-aldosterone system and kallikrein-kinin system[1]. Mechanistically, ACE converts Ang I to Ang II and degrades bradykinin, linking vasoconstrictor generation with vasodilator peptide inactivation[1][2]. In vivo, the C-domain is the predominant site for Ang I cleavage, whereas both ACE domains can hydrolyze bradykinin[3][1]. Compared with ACE2, ACE functions as a dipeptidylcarboxypeptidase, while ACE2 is a carboxypeptidase that metabolizes angiotensin peptides and is not inhibited by typical ACE inhibitors[4][5]. Therefore, ACE and ACE2 define distinct but connected enzymatic axes for cardiovascular, renal, and inflammatory research[4][6]. For experimental applications, ACE inhibitors, C-domain-selective inhibitors, and structural ACE-lisinopril complexes support studies of substrate processing, domain selectivity, and cardiovascular drug mechanisms[7][8].- C-domain inhibition helps dissect Ang I-dependent vasoconstriction without blocking all ACE activity[8]. - ACE2 comparisons separate classical ACE signaling from counter-regulatory Ang- (1-7) /Mas-axis mechanisms[6]. - ACE inhibitor models remain useful for cardiovascular, renal, bradykinin, and RAAS pathway studies[2][7].
-
Subcellular Localization
Cell membrane; Single-pass type I membrane protein; Cytoplasm; Secreted; Cell membrane; Single-pass type I membrane protein; Secreted
-
Expression
Tissue_specificity:It is widely expressed in various tissues throughout the body, with the highest expression levels in the lungs, kidneys, heart, gastrointestinal tract, and prostate; it is specifically expressed in spermatocytes and adult testes.
Induction:Up-regulated in failing heart -
Isoforms & Post-Translational Modification
P12821 has 4 isomers: P12821-1: 149715 Da (predicted); P12821-2: 131659 Da (predicted); P12821-3: 83330 Da (predicted); P12821-4: 78694 Da (predicted).
Produced following proteolytic cleavage by secretase enzymes that cleave the transmembrane form in the juxtamembrane stalk region upstream of the transmembrane region (PubMed:10769174, PubMed:11274151, PubMed:7499427, PubMed:8253769). Cleavage can take place at different sites of the juxtamembrane stalk region (PubMed:10769174, PubMed:11274151, PubMed:7499427, PubMed:8253769);Phosphorylated by CK2 on Ser-1299; which allows membrane retention (PubMed:12386153). Phosphorylated on tyrosine residues on its extracellular part, promoting cleavage by secretase enzymes and formation of the soluble form (Angiotensin-converting enzyme, soluble form) (By similarity) -
Subunit
Monomer and homodimer; homodimerizes following binding to an inhibitor (PubMed:16476786). Interacts with calmodulin (CALM1, CALM2 or CALM3); interaction takes place in the cytoplasmic region and regulates phosphorylation and proteolytic cleavage (By similarity)
-
SwissProt ID
-
Synonyms
Angiotensin Converting Enzyme 1; ACE; ACE-T; Angiotensin-converting enzyme isoform 1precursor; Dipeptidyl carboxy peptidase 1; Kininase II; ACE-1; testis-specific isoform precursor. ACE 1; ACE T; ACE1; Angiotensin converting enzyme somatic isoform; Angiotensin converting enzyme testis specific isoform; Angiotensin I converting enzyme; Angiotensin I converting enzyme 1; Angiotensin I converting enzyme peptidyl dipeptidase A 1; Carboxycathepsin; CD 143; CD143; CD143 antigen; DCP 1; DCP; DCP1; Dipeptidyl carboxypeptidase 1; MVCD3; Peptidase P; Peptidyl dipeptidase A; Testicular ECA; ACE_HUMAN.
Documentation
[1]. Masuyer G, et al. Molecular recognition and regulation of human angiotensin-I converting enzyme (ACE) activity by natural inhibitory peptides. Sci Rep. 2012;2:717. [Content Brief]
[2]. Su JB. Different cross-talk sites between the renin-angiotensin and the kallikrein-kinin systems. J Renin Angiotensin Aldosterone Syst. 2014 Dec;15(4):319-28. doi: 10.1177/1470320312474854. Epub 2013 Feb 5. PMID: 23386283. et al. Different cross-talk sites between the renin-angiotensin and the kallikrein-kinin systems. J Renin Angiotensin Aldosterone Syst. 2014 Dec;15(4):319-28. [Content Brief]
[3]. Fuchs S, et al. Angiotensin-converting enzyme C-terminal catalytic domain is the main site of angiotensin I cleavage in vivo. Hypertension. 2008 Feb;51(2):267-74. [Content Brief]
[4]. Rice GI, et al. Evaluation of angiotensin-converting enzyme (ACE), its homologue ACE2 and neprilysin in angiotensin peptide metabolism. Biochem J. 2004 Oct 1;383(Pt 1):45-51. [Content Brief]
[5]. Turner AJ, et al. ACEH/ACE2 is a novel mammalian metallocarboxypeptidase and a homologue of angiotensin-converting enzyme insensitive to ACE inhibitors. Can J Physiol Pharmacol. 2002 Apr;80(4):346-53. [Content Brief]
[6]. Iwai M, et al. Devil and angel in the renin-angiotensin system: ACE-angiotensin II-AT1 receptor axis vs. ACE2-angiotensin-(1-7)-Mas receptor axis. Hypertens Res. 2009 Jul;32(7):533-6. [Content Brief]
[7]. Natesh R, et al. Crystal structure of the human angiotensin-converting enzyme-lisinopril complex. Nature. 2003 Jan 30;421(6922):551-4. [Content Brief]
[8]. van Esch JH, et al. Selective angiotensin-converting enzyme C-domain inhibition is sufficient to prevent angiotensin I-induced vasoconstriction. Hypertension. 2005 Jan;45(1):120-5. [Content Brief]
Powered by Bioz
